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ABSTRACT: The influence of two structurally different anionic surfactants on the
anhydrous-to-dihydrate transformation of carbamazepine (CBZ) was investigated. The
surfactants studied were sodium lauryl sulfate (SLS), a surfactant commonly used in
compendial dissolution methods, and sodium taurocholate (STC), an important surfac-
tant in the solubilization and absorption of drugs and lipids in the gastrointestinal tract.
Results show that both surfactants promoted the crystallization of CBZ dihydrate
[CBZ(D)] during dissolution of the anhydrous monoclinic polymorph [CBZ(A)]). Exa-
mination of crystal surfaces showed that SLS facilitated the surface-mediated nucleation
of CBZ(D) on CBZ(A) crystals at surfactant concentrations below the critical micelle
concentration (cmc). Solubilization of a dye and related color changes provided visual
evidence for adsorbed SLS assemblies on CBZ(A) crystal faces below the cmc. Above the
cmc, both surfactants promoted the transformation by increasing the bulk nucleation of
CBZ(D). STC changed the crystal morphology of CBZ(D) from acicular to prismatic,
depending on STC concentration. Such morphology changes originate from interactions
between STC and molecular structures of CBZ(D) crystal faces that interfere with the
formation of a hydrogen-bonded chain of water molecules and carboxamide dimers.
 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:449–460, 2004
Keywords: co-crystals; clathrates; crystal engineering; crystal structure; crystal-
lization; hydrates/solvates; polymorphism
INTRODUCTION
The range of solid state forms that a drug
substance exhibits (i.e., amorphous, polymorphs,
solvates, or co-crystals) is a key issue in the de-
velopment of a pharmaceutical product because
the form can affect bioavailability and stability
in significant ways.1,2 In fact, transformations
between solid state forms can compromise disso-
lution behavior3–5 and the physical and chemical
integrity of a drug product.6,7 During dissolution
tests, for instance, solution-mediated transfor-
mations are important because the rate of the
transformation determines the concentration of
drug in solution, with faster conversion rates
leading to lower levels of drug dissolved.8,9
Solution-mediated transformations involve
three main steps: dissolution of a metastable solid
phase, nucleation, and growth of a stable solid
phase. Studies in the pharmaceutical literature
have focused on the dissolution process and the
effect of surfactants,10–12 with little attention
given to how surfactants affect the crystallization
steps involved in solution-mediated transforma-
tions. It would seem that surfactants, given their
interfacial properties and their ability to form a
variety of supramolecular structures (micelles,
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hemimicelles, etc.) in aqueous solution, could have
a profound effect on crystallization in addition to
their effects on dissolution. Surfactants have been
shown to promote or inhibit crystallization steps
(nucleation, crystal growth) in organic and inor-
ganic crystals13–18 and direct the crystallization of
solid phases that otherwise are not formed.19,20
In this paper, we examine the role of physiolo-
gically relevant surfactants and conventional
surfactants on the dissolution behavior of meta-
stable solid phases. Previous work has shown
that the monoclinic polymorph of carbamazepine
anhydrous [CBZ(A)] converts to the dihydrate
form, CBZ(D), in aqueous solution via a solution-
mediated mechanism.21–23 Carbamazepine (CBZ)
is an anticonvulsant with a narrow range of thera-
peutic efficacy, and commercial tablets of CBZ are
formulated with the anhydrous monoclinic form,
CBZ(A). The potential for a solution-mediated
transformation to the dihydrate crystal form,
CBZ(D), lies in the fact thatCBZ(A)hasa solubility
at room temperature that is at least three times
greater than that of CBZ(D) in water.23 As with
other poorly water soluble drugs, the compendial
dissolution method for CBZ tablets requires the
use of 1% sodium lauryl sulfate (SLS).24 Surfac-
tants have been shown to promote or inhibit the
growth of CBZ(D) in suspensions of CBZ(A) de-
pending on their solubilizing capacity.16,25,26 Poly-
sorbate 80 and poloxamer 184 slowed CBZ(D)
growth, whereas SLS and benzalkonium chloride
accelerated growth.Because surfactants canaffect
both dissolution and crystallization processes, it is
important to know how synthetic and biological
surfactants affect the dissolution performance of a
drug that undergoes a solution-mediated trans-
formation.
The aim of the present study was to investigate
the influence of two structurally different anionic
surfactants on the anhydrous monoclinic-to-dihy-
drate CBZ transformation in aqueous solutions.
The surfactants studied were SLS, a conven-
tional surfactant, and sodium taurocholate (STC),
an important surfactant in the solubilization
and absorption of drugs and lipids in the gastro-
intestinal tract. These surfactants have differ-
ent physicochemical properties12,27 because of
their molecular structures and self-organization
behavior.28,29 SLS has a flexible alkyl chain that
exhibits axial polarity (hydrophilic headgroupand
hydrophobic tail),whereasSTC is a trihydroxy bile
salt, with a rigid steroid ring system that exhibits
facial polarity (hydrophilic and hydrophobic
planes). Molecular structures of carbamazepine
and surfactants are shown in Figure 1. Experi-
ments were carried out to monitor the drug
concentration and solid phase composition during
the transformation, and to examine crystal sur-
faces and morphologies of dissolving CBZ(A) and
crystallizing CBZ(D). The influence of surfactants
on the phase transformation and dissolution
behavior is explained on the basis of molecular
structures of crystal surfaces and molecular and
supramolecular structures of surfactants.
EXPERIMENTAL
Materials
Anhydrous monoclinic carbamazepine [CBZ(A),
lot # 28F0109) was purchased from Sigma Chemi-
cal Company (St. Louis, MO) and used as receiv-
ed. CBZ(A) was also recrystallized from methanol
(Fisher Scientific, HPLC grade) by cooling a warm
solution of CBZ (0.14 g/mL) to 108C and harvest-
ing the solid phase after 20 min at 108C. Large
single crystals of CBZ(A) were grown by slow
evaporation at room temperature of solutions
containing CBZ in methanol (0.02–0.05 g/mL).
Carbamazepine dihydrate [CBZ(D)] was prepared
by crystallization from aqueous solutions super-
saturated with respect to the dihydrate form and
Figure 1. Chemical structures of (a) carbamazepine,
(b) sodium lauryl sulfate, and (c) sodium taurocholate.
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used for solubility and dissolution studies. Super-
saturation was created by dissolving CBZ(A) at
50–658C with constant stirring, filtering the
solution to remove any extraneous particulates,
and cooling the filtrate to 58C.
Sodium taurocholate (STC, 98% purity) and
sodium lauryl sulfate (SLS, 99% purity) were pur-
chased from Sigma Chemical Company (St. Louis,
MO) and used as received. The surfactant concen-
trations studied were above and below the critical
micellar concentration (cmc) for each surfactant.
The highest surfactant concentration studied was
17.3 mM because of the fast conversion rates of
CBZ(A) to CBZ(D) at concentrations of SLS above
this value. It is worth noting that this value cor-
responds to half of the concentration of SLS
required in the USP dissolution method for CBZ
tablets.24 The water used in this study was filter-
ed through a double-deionized purification system
(Milli Q Plus Water System from Millipore Com-
pany, Bedford, MA). Pinacyanol chloride (PC),
used in adsolubilization studies, was purchased
from Sigma Chemical Company (St. Louis, MO)
and used as received.
Solubility of Anhydrous and Dihydrate CBZ
The solubility of both CBZ(D) and CBZ(A) was
determined by the equilibrium and dissolution
methods as described in a previous publication.23
Solubilities reported in the present work were
measured in aqueous solutions at surfactant
concentrations in the range 2.0–17.3 mM at 258C.
Transformation of Anhydrous to Dihydrate CBZ
The transformation from CBZ(A) to CBZ (D) was
studied from suspensions of CBZ(A) in solutions
initially supersaturated with respect to the dihy-
drate phase at 258C by the methods described in
detail previously.23 The solution-mediated trans-
formation of CBZ(A) to CBZ(D) was characterized
by monitoring the following: CBZ concentration
in solution, solid phase composition, and crystal
morphology during the transformation. The stu-
dies reported here were carried out at a super-
saturation of 0.15 or 1.15 times the solubility of
the dihydrate form in all the surfactant solutions.
Supersaturation is defined as sD¼ (C/SD) 1,
where C is the CBZ concentration in solution
and SD the solubility of CBZ(D).
Solutions were pre-supersaturated at 258C by
dissolving CBZ(A) at 608C in surfactant solutions,
filtering through a 0.22-mm filter, and quickly
cooling to 258C in ice. Five hundred milligrams of
CBZ(A) and 250mL of the solution supersaturated
with respect to CBZ(D) were added to a jacketed
beaker, with temperature controlled at 25 18C
(Neslab RTE 210, Portsmouth, NH). The specific
surface area of CBZ(A) was 0.07 m2/g as measur-
ed by the Brunauer—Emmett—Teller method
(Quantasorb Surface Area Analyzer, Quanta-
chrome Company, Boynton Beach, FL). The sus-
pension was stirred at 400 rpm. Aliquots of the
suspension were withdrawn at various time inter-
vals with a plastic syringe and filtered through a
0.45-mm Millipore filter in a 13-mm Swinex disc
filter holder. The filtrate was appropriately dilut-
ed, and the concentration of CBZ in solution was
measured by ultraviolet (UV) spectrophotometry
at 284.5 nm with a Perkin-Elmer Lambda 7 UV–
visible (UV–vis) spectrophotometer (Shelton, CT).
The methods for analyzing the solid phase
during the transformation have been described
previously,23 including X-ray powder diffraction
(XRPD), differential scanning calorimetry (DSC),
and weight loss on drying. At periodic intervals
during the transformation of CBZ(A) to CBZ(D),
5–10 mL of the suspension were filtered under
reduced pressure (25 mmHg) for 40 min to remove
physically bound water.22 The weight fraction of
CBZ(A) and CBZ(D) was quantified by comparing
the percent weight loss of dried samples to a stan-
dard curve based on physical mixtures of known
composition of CBZ(A) and CBZ(D). An ultrami-
crobalance (Mettler UM-3) was used to weigh the
solid phase (3–10 mg 1 mg).
Crystal Morphology of CBZ(D)
To identify the morphologically important faces of
CBZ(D), single crystals were grown at 258C, in the
presence of 2.0–9.0 mM STC and at a constant
supersaturation of 1.5, in a flow cell apparatus
previously described by our group.30,31 The mor-
phology of crystals in the glass flow cell (0.25
0.50 3.0 cm) was monitored with an inverted
microscope (Nikon, Diaphot-TMD, Nikon Inc.,
Melville, NY) using a 40 long working distance
objective.
The Miller indices of the CBZ(D) crystal faces
were calculated from the interfacial angles that
were measured with a two-circle reflecting goni-
ometer. The Miller index of each morphologically
important crystal face was calculated with the
equation that relates the interplanar angles to the
unit cell lattice parameters reported for CBZ(D).32
The crystallographic axes were verified with a
SURFACTANT EFFECTS ON CARBAMAZEPINE CRYSTALLIZATION 451
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 93, NO. 2, FEBRUARY 2004
precession camera and by comparing the mea-
sured interlattice spacings from the zero level
precession photographs to the reported lattice
parameters.
Microscopy
CBZ solid was examined during the transforma-
tion while suspended in the transformation
medium with an inverted light microscope
(Nikon, Diaphot-TMD, Nikon Inc., Melville, NY),
with 10 and 40Nomarski objectives. Solid
phases were also examined, by scanning electron
microscopy (SEM; Hitachi S-3200N, Tokyo,
Japan). Samples were prepared by transferring
the CBZ solid to a strip of double-sided carbon
tape (Ted Pella, Inc., Redding, CA) attached to a
standard SEM mounting stub. The samples were
subsequently coated with gold for 200 s (Desk II,
Denton Vacuum, Moorestown, NJ) to prevent
charging at the surface. The microscope was
operated with 15 kV beam current.
X-ray Powder Diffraction
The XRPD patterns were recorded using a
Scintag X-ray diffractometer (Franklin, MA)
using CuKa radiation (l¼ 1.5418 Å), tube voltage
of 35–45 kV, tube current of 20–40 mA, 2y of
2–508, scan rate of 58/min, and step size of 0.0208.
Differential Scanning Calorimetry
The thermal properties of CBZ were determined
by DSC with a Perkin-Elmer DSC-7 (Shelton,
CT). Samples were weighed into aluminum pans
that were then sealed with a crimper. The ther-
mal behavior was studied under a dry nitro-
gen purge (20 mL/min) at a heating rate of 108C/
min.
Adsolubilization
The method described by Nun et al.33 for visual
evidence of solubilization of a dye on an alumina
surface as a result of surfactant aggregation or
surface micelle formation was used to test for the
presence of adsorbed surfactant layers that can
adsolubilize solute molecules. PC was added to
suspensions of CBZ(A) containing 4.3 mM SLS to
achieve a dye concentration of 1 105 M. The
systems were initially undersaturated with re-
spect to both anhydrous and dihydrate CBZ to
retard the anhydrous-to-dihydrate CBZ trans-
formation. Suspensions of CBZ(A) containing
PC in the absence of SLS served as a control.
Suspensions were placed in scintillation vials
and shaken (Speci-Mix mixer, Thermolyne Corp.,
Dubuque, IA) at room temperature (228C). The
solution and solid surfaces were visually exam-
ined for color changes. In the presence of SLS, a
reddish dye salt–SLS complex forms at concen-
trations below the cmc, and the solution shows a
red color.34 When the dye–SLS salt is solubilized
and incorporated within surfactant micelles the
solution turns blue similar to when PC is
dissolved in organic solvents. Even though this
method is not reliable for cmc measurement be-
cause of the formation of mixedmicelles with SLS,
it indicates the solubilization of the dye in the
hydrocarbon phase of the micelles. This model has
been confirmed by Sato et al. with fluorescence
decay measurements.35
Surface Tension Measurements
The cmc of SLS was determined in aqueous solu-
tions in the absence and presence of carbama-
zepine (0.16 mg/mL) from the surface tension
dependence on surfactant concentration.11 The
surface tension of solutions was measured at 258C
by the Wilhelmy Plate method with a platinum
plate36 (Rosano surface tensiometer, Laboratory
Products, Inc., Boston, MA). The instrument was
calibrated with known weights, and determi-
nation of surface tension was verified by compar-
ison of measured and reported values for water.
The cmc was evaluated from the break in the




The solubility of CBZ increases to different
degrees in both SLS and STC aqueous solutions.
Solubilization curves show that the solubility of
CBZ(D) is equal to its aqueous solubility at surfac-
tant concentrations below the cmc and increases
linearly above the cmc (Figure 2). The solubility of
CBZ(D) increased by as much as eight-fold at an
SLS concentration of 17.3 mM. This SLS concen-
tration corresponds to half of the concentration of
SLS required in the dissolution media according
to the USP monograph for CBZ tablets.24 CBZ in
solution (0.16 mg/mL) decreased the cmc of SLS
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from 6.7 to 5.3 mM at 258C. The cmc in the ab-
sence of CBZ is lower than the reported value of
8.3 mM37 because of the presence of surface-active
impurities and is in agreement with the value
reported by Crison et al.11
The solubility of CBZ(D) increased 1.7 times in
the presence of 17.3mMSTC (Table 1). Solubiliza-
tion of CBZ was not observed at STC concentra-
tions at or below 5.0 mM. The cmc of STC is poorly
defined because of the progressive self-association
over a range of concentrations,28,38 and cmc values
in the range 2.5–12.0 mM in water at 258C, have
been reported.27
Themolar solubilization capacity, k, represents
themoles of drug solubilized permole of surfactant
(k¼Sm/Cmic39) and was evaluated for CBZ(D) ac-
cording to the following equation:
Stot ¼ Sw þ Sm ¼ Sw þ kðCmicÞ ð1Þ
where Cmic is the molar concentration of micellar
surfactant, Sm is the molar solubility of the
solute in the micellar phase, Sw is the solubility
of the solute in water, and Stot is the total solubi-
lity. The molar solubilization capacity for CBZ(D)
in SLS is 10 times greater than that in STC (i.e.,
0.33 and 0.03, respectively). The micellar parti-
tion coefficient, Km (¼Sm/Sw), is related to the
solubility of the solute in water and was used to
estimate the solubilization of CBZ(A) at surfac-
tant concentrations for which the experimental
solubility was not measured (Table 1). There
is good agreement between the estimated and
measured solubility values. The lower values for
the experimentally determined solubilities are
a result of faster transformation rates to the dihy-
drate form with increasing surfactant concentra-
tion, as discussed later. The solubility of CBZ(A)
is about three-fold higher than the solubility of
CBZ(D) at 258C, in the presence and absence of
surfactants.
Effect of SLS on the Transformation Kinetics
SLS increased the anhydrous-to-dihydrate CBZ
transformation rate at concentrations of4.3 mM
(Figure 3). At lower SLS concentrations (3.5 mM),
dissolution of the anhydrous phase maintain-
ed a supersaturated state with respect to the di-
hydrate form, with undetectable formation of
Table 1. Solubility of Anhydrous and Dihydrate CBZ at 258C as a Function of
Surfactant Concentration
Surfactant (mM) CBZ(A)a (mg/mL) CBZ(D) (mg/mL)
SLS 0 0.38 0.03b [0.38]c 0.125 0.002
3.5 0.38 0.00 [0.38] 0.127 0.001
5.0 [0.41] 0.135 0.001
9.0 [1.05] 0.361 0.001
15.0 [2.43] 0.828 0.008
17.3 2.60 0.26 [3.01] 1.030 0.003
STC 0 0.38 0.03 [0.38] 0.125 0.002
2.0 0.36 0.04 [0.38] 0.127 0.001
5.0 [0.38] 0.126 0.001
9.0 0.40 0.01 [0.47] 0.155 0.001
15.0 [0.58] 0.196 0.001
17.3 [0.61] 0.214 0.001
aSolubility calculated from the intrinsic dissolution rate method.
bMean standard error (n¼ 3).
cIn brackets, solubility estimated according to the following equation: (Stot/Sw)¼ 1þKm.
Figure 2. Solubility of CBZ(D) as a function of
surfactant concentration. Key: (*)SLS, (*)STC.
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dihydrate in 24 h. This behavior was observed at
initial supersaturations as high as 1.31 in 3.5 mM
SLS. At 4.3 mM and above, during the initial
dissolution stage, CBZ concentrations in solution
reached a maximum supersaturation followed by
a decrease to a plateau supersaturation as a result
of the relative rates of dissolution of CBZ(A) and
crystallization of CBZ(D). Both the maximum and
plateau concentrations decreased with increasing
SLS concentration. This result suggests that SLS
decreased the threshold concentration for nu-
cleation and increased the crystallization rate of
CBZ(D) at a faster rate than the dissolution of
CBZ(A). Microscopic examination of the solid
phase showed needles of CBZ(D) growing on the
surface of the dissolving CBZ(A), which is evi-
dence of a heterogeneous nucleation mechanism
(Figure 4). Solid-phase analysis showed as much
as 50% CBZ(A) remaining undissolved by 24 h for
the 9.0 and 17.3 mM SLS, despite steady-state
concentrations close to the equilibrium solubility
of CBZ(D). This result is because of the extensive
surface nucleation of CBZ(D) that decreases the
surface of CDZ(A) in contact with the solution
phase.
Monitoring CBZ(A) single crystals during the
transformation showed that surface-mediated
nucleation of CBZ(D) on CBZ(A) increases with
SLS concentration and that it is not specific to a
given CBZ(A) crystal face. CBZ(A) single crystals
grown by slow evaporation from 2 and 5% CBZ in
methanol solutions exhibit well developed {001},
{111}, and {101} faces (Figure 5) and have a
morphology that is similar to that of commercially
availableCBZ(A) crystals.Needles ofCBZ(D) grew
at random orientations on all faces of single
crystals of CBZ(A) within 20 min in 17.3 mM SLS
at initial supersaturation of 0.15, whereas surface
nucleationwas not observed for 24h in the absence
of surfactant (Figure 5).
To understand the heterogeneous nucleation of
CBZ(D) and the association of SLS on the CBZ(A)
surface, studies were done with a dye (PC) that
changes color as a result of micellar solubilization.
PC, a dye of the cyanine class, has been used to
provide visual evidence for the presence of adsorb-
ed surfactant layers that can adsolubilize solute
Figure 3. Effect of SLS concentration on the super-
saturation profile during the transformation of anhy-
drous to dihydrate carbamazepine. Initial (C/S) 1¼
0.15 at 258C. Key to SLS concentration (mM): (~) 0.0;
(&) 3.5; (*) 4.3; (~) 9.0; (*) 17.3. The solid phase
composition, percent (w/w) of CBZ(D) in the solid phase
with standarddeviation inparentheses, is noted for each
concentration.
Figure 4. Photomicrographs of CBZ(D) crystals
grown during transformation experiments, at initial
supersaturation of 0.15 and 258C: (a) absence of sur-
factants, (b) 17.3 mM SLS, and (c) 17.3 mM STC. Scale
Bar: (—) 200 mm.
Figure 5. Photomicrographs of single crystals of
CBZ(A) during the transformation to CBZ(D) in the
presence of SLS. The characteristic morphology of
crystals grown by slow evaporation of 2 and 5% w/w
CBZ inmethanol at 258C is shown: (a) crystals placed in
aqueous solutions without surfactant at (C/S) 1¼ 0.15
for 24 h; and (b) crystals placed in a solution of 17.3 mM
SLS at (C/S) 1¼ 0.15 for 20 min.
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molecules.33 At SLS concentration of 4.3 mM, a
value below the cmc, the color of CBZ(A) crystal
surface became blue, which is characteristic of PC
solubilized inmicelle. In contrast, the supernatant
solution remained red, which is characteristic of
PC in a hydrophilic environment. When suspend-
ed in aqueous solutions containing PC in the
absence of SLS, the color of the CBZ(A) crystal
surface remained white. These observations sug-
gest that PC is solubilized into a micelle-like
environment on the surface of the CBZ(A) crystals
as a result of two-dimensional assemblies of SLS.
Effect of STC on the Transformation Kinetics
STC increased the anhydrous-to-dihydrate CBZ
transformation (Figure 6) at surfactant concen-
tration of 17.3 mM, and 78% of the solid phase
consisted of the dihydrate form by 24 h. At STC
concentrations of 9 mM, formation of CBZ(D)
was negligible for 24 h (i.e., below the detection
limits, <5%, of XRD and optical microscopy),
despite the solution being supersaturated with
respect to this form.
Comparing the behavior of systems with SLS
and STC showed that crystallization of CBZ(D)
occurs earlier and at lower supersaturations in
solutions with SLS (Figure 7). In the presence
of STC, higher supersaturations were achieved
before crystallization of CBZ(D) began to deplete
the supersaturation, and the rate of desupersa-
turationwas slower than in thepresence of SLS.At
17.3 mM surfactant concentration, CBZ(D) crys-
tals appeared within 10 min in SLS compared to
1 h in STC.However, a higher fraction of CBZ(A)
remained unchanged in solutions with SLS com-
pared with STC; that is, 50 and 22%CBZ (A) in the
solid phase, respectively, and a supersaturation of
0.2 within 24 h.
STC significantly changed the crystal morphol-
ogy of CBZ(D) (Figures 4 and 8), whereas hetero-
geneous nucleation of CBZ(D) on the surface of
the anhydrous form did not occur to a significant
extent. XRPD and zero-level precession photo-
graphs do not reveal differences in the unit cell
dimensions of CBZ(D) grown in solutions with and
without STC. There were also no differences in the
thermal behavior during dehydration and subse-
quent melt of CBZ(D) crystallized in the presence
or absence of STC. This result suggests that STC
was not incorporated within the CBZ(D) crystal
lattice and that the crystal morphology change is a
result of interactions between STC and specific
crystal faces of the dihydrate form.
The characteristic morphology of CBZ(D) crys-
tals grown from water only, SLS, and STC during
dissolution of CBZ(A) is shown in Figure 4. In
water only and in SLS solutions, growth along the
b-direction, [010], is fastest, and faces that are
perpendicular to this direction have very
small surface areas. Consequently, CBZ(D) crys-
tals grown from these solutions are needles
elongated along the [010] direction. In contrast,
CBZ(D) crystals grown during the transformation
Figure 6. Effect of STC concentration on the super-
saturation profile during the transformation of anhy-
drous to dihydrate CBZ. Initial (C/S) 1¼ 0.15 at 258C.
Key toSTCconcentration (mM): (~) 0.0; (&) 2.0; (*) 9.0;
(*) 17.3. The solid phase composition,%(w/w) of CBZ(D)
in the solid phase with standard deviation in parenth-
eses, is noted for each concentration.
Figure 7. Comparison of surfactant effect on the
supersaturation behavior and solid phase composition.
Initial (C/S) 1¼ 0.15 at 258C. Key: (~) water; (&)
17.3 mM STC; (*) 17.3 mM SLS. The solid phase
composition, %(w/w) of CBZ(D) in the solid phase with
standard deviation in parentheses, is noted for each
concentration.
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in 17.3 mM STC show a more isometric shape and
diminished growth along the [010] direction.
Single crystal growth experiments, carried out
at constant supersaturation of 1.5 during growth,
confirmed that CBZ(D) morphology is dependent
on STC concentration (Figure 8). Plates were
grown in 5.0 mM STC and bipyramids in 9.0 mM
STC,with the crystalhabit dominatedby the {111},
{002}, and {200} faces. Thus, STC inhibits the rela-
tive growth rate of CBZ(D) along the b-direction,
and increases the surface area and morphological
significance of {111} faces.
DISCUSSION
In an earlier publication, our group showed that
CBZ(A) transforms to CBZ(D) by a solution-
mediated process.23 In this process, the concen-
tration of drug in solution and the extent of the
phase transformation depend on the rate of dis-
solution of the metastable phase [CBZ(A)] and the
rates of nucleation and growth of the stable phase
[CBZ(D)]. We have shown that milling of CBZ(A)
changes the rate-controlling process from crystal-
lization of CBZ(D) to dissolution of CBZ(A).
In addition to solid-state processing, solution-
mediated transformations are sensitive to solution
conditions (additives, pH, supersaturation, and
temperature). The experimental results present-
ed in this paper indicate that both surfactants,
SLS and STC, increase the transformation rate of
CBZ(A) to CBZ(D), and that the onset, extent, and
mechanism of CBZ(D) crystallization depend on
surfactant molecular structure, concentration,
and supramolecular association. The general
shape of the supersaturation profiles shows that
surfactants change the rate-controlling step from
crystallization of CBZ(D) to dissolution of CBZ(A)
as the surfactant concentration increases and that
SLS is more effective than STC in increasing the
rate of crystallization. The discussion that follows
examines the effect of surfactant structure and
concentration on surfactant self-association, inter-
action with CBZ crystal faces, CBZ solubilization,
hydrogen bonding, CBZ(D) crystal morphology,
CBZ(D) nucleation, and crystal growth.
Microscopic examination of the solid phases
during the transformation revealed that SLS
facilitates the surface-mediated nucleation of
CBZ(D) on the dissolving CBZ(A). Systems with
STC and without surfactants do not exhibit this
behavior. The greater extent of heterogeneous
nucleation in thepresence of SLSmaybea result of
adsorption of SLS at the CBZ(A) crystal–solution
interface and solubilization of CBZ in these ad-
sorbed SLS assemblies. Solubilization of PC at the
CBZ(A) crystal–solution interface confirms the
presence of surface assemblies of SLS below
the bulk cmc capable of adsolubilizing or coad-
sorbing CBZ, since SLS micelles solubilize CBZ
(Figure 2). A number of compounds, including
steroids,40 styrene,41 and dyes,42 are solubilized by
adsorbed surfactant layers and hemimicelles or
two-dimensional micelles on solid surfaces. This
solubilization will lead to high interfacial concen-
trations of CBZ on the dissolving anhydrous
surface and provide the driving force for crystal-
lization of CBZ(D) on the surface of CBZ(A).
Micelle-mediated crystallization is also supported
by the lower supersaturation threshold for nuclea-
tion of CBZ(D) at SLS concentrations above the
cmc. Luhtala25 has reported similar behavior,
although transformation studies were done
under unstirred conditions by measuring the total
particle size distributions of CBZ(A) suspensions.
The studies of Luhtala and co-workers show that
SLS25 and benzalkonium chloride15 accelerate the
crystallization of CBZ(D) during dissolution of
CBZ(A) at surfactant concentrations above the
cmc.
Surfactant assemblies can promote crystalliza-
tion by acting as templates for the nucleation and
growth of crystals14,20 and/or by solubilizing, and
thus concentrating solute molecules in micelles.17
The former mechanism explains the increase in
the transformation rates of CBZ(A) to CBZ(D)
in the presence of STC because there is a small
Figure 8. Crystal morphology of CBZ(D) grown in (a)
water, (b) 5 mM STC, and (c) 9 mM STC at constant
supersaturation (C/S) 1¼ 1.5 and 258C.
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increase in the solubilization of CBZ,whereas both
templating and solubilization may be effective in
the presence of SLS. The latter mechanism was
proposed to accelerate the crystallization rate
of CBZ(D) in both benzalkonium chloride and
SLS.15,25 Nucleation and crystal growth models
predict an increase in rates with increasing solu-
bility when the supersaturation is constant.9,43
This prediction is due to a decrease in the inter-
facial tension and an increase in the frequency of
molecular collisions with increasing solubility.
Surfactants can also retard crystallization when
the increase in solubility is compensated by inter-
molecular interactions between surfactant and
crystallizing solute that interfere with the forma-
tion and growth of stable nuclei.13,18,19
Morphology or crystal shape changes of organic
materials have been thoroughly studied31,44,45 and
are due to different crystal faces that can grow at
different rates dependingon the solvent, additives,
impurities, and supersaturation. When growth of
a crystal face is inhibited, the surface area of this
face is expected to increase relative to the areas of
other faces, because growth of a face is defined as
the rate at which the face grows perpendicular to
itself. In this way, crystal morphology changes,
and the well-defined arrangement of molecules on
crystal surfaces offer a means to probe molecular
recognition events at interfaces. CBZ(D) grows as
needles with fastest growth along the b-axis in the
absence of surfactant and in systems with SLS,
whereas it grows as prismatic crystals with well-
defined {111}, {002}, and {200} faces and decreased
growth rate along the b-axis in the presence of STC
(Figures 4 and 8). This change in morphology
suggests specific interactions between STC and
the functional groups on the {111} faces of CBZ(D).
To understand this preferential interaction, we
examined the crystal structure of CBZ(D), the
molecular interactions along morphologically im-
portant faces, and the conformation and supramo-
lecular structures of STC. The crystal structure
of CBZ(D) is characterized by hydrogen bonds
forming dimers, chains, and tapes.32,46 Signifi-
cant interactions of the {111} faces and along the
b-direction of CBZ(D) crystals include a channel of
hydrogen-bonded water molecules and p–p inter-
actions between the aromatic regions of CBZ
molecules (Figure 9). This direction of growth is
expected to be the fastest, in the absence of solvent
or additive effects, because it has the strongest
intermolecular interactions and the shortest unit
cell dimensions. CBZ molecules form centrosym-
metric dimers by hydrogen bonding between
carboxamide groups along the c-axis (Figure 10).
Growth of faces perpendicular to this axis, {002}
faces, involves hydrogen-bonded homodimers
between CBZ molecules and water molecules.
Growth perpendicular to the {200} faces and along
the a-direction results from hydrogen bonding
betweenwatermolecules and carboxamide groups
forming a tape. Morphology predictions will be
addressed in a subsequent publication. Based on
unit cell dimensions and attachment energy
calculations, morphology predictions identified
the {111}, {002}, and {200} faces asmorphologically
significant and the b-axis as the longest crystal
dimension, which is in agreement with the experi-
mental results presented here.47,48
Figure 9. CBZ(D) crystal lattice viewed down the
a-axis, showing the hydrogen bonding along the b-axis.
Space group Cmca, unit cell dimensions: a¼ 19.748 Å,
b¼ 4.924 Å, c¼ 28.659 Å, a¼ b¼ g¼ 908.
Figure 10. CBZ(D) crystal lattice viewed down the
b-axis. A molecular tape is formed between alternating
CBZ dimers and water molecules.
SURFACTANT EFFECTS ON CARBAMAZEPINE CRYSTALLIZATION 457
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 93, NO. 2, FEBRUARY 2004
Examination of bile acid supramolecular assem-
blies in aqueous solutions and in the crystalline
state conveys valuable information about the
relationship between molecular structures and
resultant micelles or supramolecular structures.
STC molecules exhibit facial polarity, with the
hydrophilic part consisting of three hydroxyl
groups and a sulfonate group situated below the
equator of the rigid steroid ring, and with the
hydrophobic methyl groups situated above this
equator28,49 (Figures 1 and 11). In contrast to alkyl
chain surfactants, such as SLS, that exhibit axial
polarity, well-defined cmc values, and homoge-
neous distribution of micellar aggregates with
aggregation numbers of at least 50,50 bile salts
exhibit a wide range of cmc values because of their
progressive association and heterogeneous distri-
bution of aggregates.29,38,51 In the case of STC,
micellar aggregates are dimers or tetramers, with
the hydrophobic surfaces of the molecules back-to-
back towards the interior of the aggregate and
the hydrophilic groups in contact with the
aqueous environment.27,28 At concentrations STC
is <50 mM, distributed as monomers, dimers, and
perhaps tetramers.28
In addition to hydrophobic interactions, inter-
molecular hydrogen bonding has also been pro-
posed to occur in larger bile salt oligomers,28,29 by
considering nonpolar and polar interactions that
stabilize these assemblies in both liquid and cry-
stalline states. STC hydrate crystals have bilayer-
ed structures with hydrophilic and hydrophobic
regions formed through intralayered, cyclic hydro-
gen bonds49,50 (Figure 11). The hydrophilic intra-
layer constitutes extensive hydrogen bondingwith
hydroxyl groups of the steroid moiety, the amino
and sulfonate groups of the taurine chain, and
water, whereas the hydrophobic layer is composed
of the steroid structure and the methyl groups.
Stacking of the hydrophobic sides of STC in the
crystal is analogous to their assembly in aqueous
solutions. Considering the structure of STC as-
semblies at the bile salt concentrations studied
here and the molecular arrangement of CBZ on
morphologically important faces, the morphology
change in the presence of STC can be explain-
ed by hydrogen bonding between the hydroxyl and
sulfonate groups of STC and the lattice water and
carboxamide group exposed on the surface of the
{111} faces of CBZ(D) crystals. The dependence of
morphology change on STC concentration and the
structure of surfactant assemblies in solutionwith
exposed functional groups that can form hydrogen
bondsunder these conditions support the proposed
model.
CONCLUSIONS
The results of this study show that surfactants
affect the solution-mediated transformation of
drugs in significant ways, and that the rate and
mechanism of the conversion depends on the
molecular and supramolecular structures of sur-
factants in solution and at crystal–solution inter-
faces. Both surfactants, SLS and STC, increased
the anhydrous-to-dihydrate CBZ transformation
in aqueous solutions depending on the type and
concentration of surfactant. SLS promoted the
surface-mediated nucleation of CBZ(D) on the
CBZ(A) crystals at surfactant concentrations
below the cmc and had little effect of CBZ(D)
morphology. Above the cmc, both surfactants
promoted the transformation by increasing the
bulk nucleation of CBZ(D). STC changed the cry-
stal morphology of CBZ(D) from acicular to pris-
matic, depending on STC concentration. Such
morphology changes originate from interactions
between STC and molecular structures of CBZ(D)
crystal faces that interfere with the formation of a
hydrogen-bonded chain of water molecules and
carboxamide dimers. The hydrogen bonding
potential of the surfactant has a significant effect
on the morphology of CBZ(D) crystals. Compared
with SLS, with only hydrogen bond acceptor
potential, STC has four hydrogen bond donor
groups and three hydrogen bond acceptors. The
Figure 11. Bilayers in hydrated STC crystal com-
prise hydrophobic and hydrophilic layers with extensive
hydrogen bonds involving hydroxyl and taurine groups
of STC molecules and water molecules. Water oxygens
are shown as large spheres and sodium ions as small
spheres. Hydrogen atoms are omitted for the sake of
clarity.
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results of this study emphasize the important role
of surfactants and crystallization in determining
the dissolution behavior of metastable solid forms
of a drug substance and in developing meaningful
dissolution methods.
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